- Home
- MHO vs RLAY Comparison
MHO vs RLAY Comparison
Compare MHO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHO | RLAY |
|---|---|---|
| Founded | 1976 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MHO | RLAY |
|---|---|---|
| Price | $130.37 | $12.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $160.00 | $19.50 |
| AVG Volume (30 Days) | 210.8K | ★ 3.6M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 2.55 | N/A |
| Revenue | ★ $4,417,781,000.00 | $15,355,000.00 |
| Revenue This Year | $0.66 | N/A |
| Revenue Next Year | $6.97 | $324.03 |
| P/E Ratio | $51.76 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $103.52 | $2.71 |
| 52 Week High | $158.92 | $17.32 |
Technical Indicators
Market Signals| Indicator | MHO | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 45.40 |
| Support Level | $125.38 | $6.67 |
| Resistance Level | $140.08 | $17.32 |
| Average True Range (ATR) | 3.88 | 1.05 |
| MACD | 0.71 | -0.54 |
| Stochastic Oscillator | 56.54 | 9.98 |
Price Performance
Historical ComparisonAbout MHO M/I Homes Inc.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.